Clinical Trials

Study Title:
A Phase 1b Open Label Study to Evaluate the Safety and Anti cancer Activity of Loncastuximab Tesirine in Combination with Other Anti cancer Agents in Patients with Relapsed or Refractory B cell Non Hodgkin Lymphoma (LOTIS 7)

For more information about the trial above please contact the study team:

Medical University of South Carolina
Principal Investigator, Brian Hess, at
Study Coordinator, Sarah Britton, at, or please call +1 843-792-8057.

Trial opened at the following institutions: Medical University of South Carolina